Colossal Biosciences Raises $200 Million at a $10.2 Billion Valuation
- Joshua Hawley
- Jan 20
- 2 min read
IGA Staff
Jan 20, 2025
Colossal Biosciences, a trailblazing genetic engineering company, is at the forefront of using advanced genomic tools like CRISPR to rewrite the future of conservation. The company’s ambitious projects focus on reviving extinct species, such as the woolly mammoth, and protecting critically endangered ones. By leveraging groundbreaking biotechnology, Colossal aims to restore biodiversity, bolster ecological resilience, and address climate challenges. Its work represents a bold new chapter in conservation, where humanity takes an active role in repairing ecosystems and sustaining life on Earth.
A $10.2 Billion Vision
In its latest funding milestone, Colossal Biosciences secured $200 million in a Series C round led by TWG Global, elevating the company’s valuation to $10.2 billion. To date, Colossal has raised $435 million, underscoring strong investor confidence in its mission. “Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” said TWG Global CEO Mark Walter. He lauded the company’s world-class team for driving rapid advancements in conservation-focused technology.
Innovation Across Disciplines
Founded in 2021 in Dallas, Texas, by Ben Lamm, Kent Wakeford, and Peter Phillips, Colossal Biosciences has quickly become a leader in high-impact markets at the crossroads of biotechnology, wildlife conservation, and climate-focused solutions. Since joining the unicorn club in 2023, the company has continued to innovate, utilizing AI and computational biology to push the boundaries of what’s possible in genetic engineering.
A Call to Action
Colossal’s mission extends far beyond technological breakthroughs. By integrating science with environmental stewardship, the company seeks to restore balance to ecosystems and ignite a global movement toward proactive conservation. Its work is not just about reviving the past—it’s about creating a sustainable future where biodiversity thrives.
For investors and stakeholders looking to make a tangible impact on conservation and climate action, Colossal Biosciences offers a transformative vision backed by cutting-edge innovation. The company’s approach redefines the role of biotechnology in addressing some of the planet’s most pressing challenges.
Comentarios